Skip to main content
OpenTrials

Clinical trial condition

Metabolic Diseases

Explore clinical trials studying Metabolic Diseases. Study availability and eligibility vary by location and protocol.

584 public trials 117 recruiting studies
Refine in advanced search Browse all conditions

Metabolic Diseases trial results

Completed

An Extension Study of an Investigational Drug, Lumasiran (ALN-GO1), in Participants With Primary Hyperoxaluria Type 1

NCT03350451

Conditions
AGT, Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +16 more
Locations
  • Clinical Trial Site Bordeaux, France
  • Clinical Trial Site Lyon, France
  • Clinical Trial Site Paris, France
  • Clinical Trial Site Bonn, Germany
View Trial Details
Completed

A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH

NCT04048135

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +4 more
Locations
  • 89bio Clinical Study Site Madison, Alabama, United States
  • 89bio Clinical Study Site Chandler, Arizona, United States
  • 89bio Clinical Study Site Tucson, Arizona, United States
  • 89bio Clinical Study Site Chula Vista, California, United States
View all 26 locations
View Trial Details
Completed

Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes

NCT03653091

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Florida Hospital / TRANSLATIONAL RESEARCH INSTITUTE FOR METABOLISM AND DIABETES (TRI) Orlando, Florida, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States
  • University of Pennsylvania - Penn Metabolic Medicine Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions